Page 7 - Pastric News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pastric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pastric Today - Breaking & Trending Today

Medicine overuse to treat gastric issues may cause serious side effects

Gastric medicine side effects: Overuse of medicine to treat gastric issues may cause serious side effects, doctors at Bangabandhu Sheikh Mujib Medical University (BSMMU) said today. ....

Razibul Alam , Moudud Sujan , Sharfuddin Ahmed , Bangabandhu Sheikh Mujib Medical University , Gastroenterology Department , Proton Pump Inhibitors , Prof Sharfuddin Ahmed , Medicine Overuse , Gastric Issues , Astric Treatment , Astric Medicine Side Effects , Reat Gastric Issues , Medicine Side Effects , Smmu Doctors , Smmu Seminar , Stomach Pain ,

SOTIO Biotech: SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pancreatic Cancer

CLAUDIO-01 is the first-in-human trial of SOT102, a CLDN18.2 (Claudin 18.2) targeting antibody-drug conjugate (ADC)The trial will enroll up to 109 patients with gastric and pancreatic cancer PRAGUE ....

Czech Republic , United States , Kostenloser Wertpapierhandel , Radka Obermannova , Josep Tabernero , Michael Tattory , Radek Spisek , Richard Kapsa , Lifesci Communications , Hebron University Hospital , Masaryk Memorial Cancer Institute , Medical Oncology ,

Keymed: FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies

CHENGDU, China, April 20, 2022 /PRNewswire/ Keymed Biosciences (2162.HK) announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for ....

Prnewswire Keymed Biosciences , Drug Administration , Track Designation , Orphan Drug Designation ,

Keymed: CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States

CHENGDU, China, April 12, 2022 /PRNewswire/ Keymed Biosciences (2162.HK) announced that its new drug candidate CMG901 (the "Claudin 18.2 antibody drug conjugates") for the treatment of gastric ....

United States , Keymed Biosciences , Prnewswire Keymed Biosciences , Drug Administration Of The United States , Orphan Drug Designation , Drug Administration , Joy Yan , Keymed Biosciences Chief Medical Officer ,

Imugene, Merck To Evaluate HER-Vaxx - KEYTRUDA Combination In Phase 2 Trial For Gastric Cancer

KENILWORTH (NJ) (dpa-AFX) - Imugene (IMU.AX) said that it has reached a new clinical trial collaboration and supply agreement with Merck & Co Inc. (MRK) to evaluate the safety and efficacy of Imugene's ....

Merck Co Inc ,